Reactive oxygen species have been implicated in neuronal injury associated with various neuropathological disorders. However, little is known regarding the relationship between antioxidant enzyme capacity and resultant toxicity. The antioxidant pathways of primary cerebrocortical cultures were directly examined using a novel technique that measures pentose phosphate pathway (PPP) activity, which is enzymatically coupled to glutathione peroxidase (GPx) detoxification of hydrogen peroxide (H2O2). PPP activity was quantified from data obtained by gas chromatography/mass spectrometry analysis of released labeled lactate following metabolic degradation of [1,6‐13C2,6,6‐2H2]glucose by cerebrocortical cultures. The antioxidant capacity of these cultures was systematically evaluated using H2O2, and the resultant toxicity was quantified by lactate dehydrogenase release. Exposure of primary mixed and purified astrocytic cultures to H2O2 caused stimulation of PPP activity in a concentration‐dependent fashion from 0.25 to 22.2% and from 6.9 to 66.7% of glucose metabolized to lactate through the PPP, respectively. In the mixed cultures, chelation of iron before H2O2 exposure was protective and resulted in a correlation between PPP saturation and toxicity. Conversely, addition of iron, inhibition of GPx, or depletion of glutathione decreased H2O2‐induced PPP stimulation and increased toxicity. These results implicate the Fenton reaction, reflect the pivotal role of GPx in H2O2 detoxification, and contribute to our understanding of the etiological role of free radicals in neuropathological conditions.

Time courses of incorporation of 13C from 13C-labelled glucose and/or acetate into the individual carbon atoms of amino acids, citrate and lactate in depolarized cerebral tissues were monitored by using 13C-n.m.r. spectroscopy. There was no change in the maximum percentage of 13C enrichments of the amino acids on depolarization, but the maxima were reached more rapidly, indicating that rates of metabolism in both glycolysis and the tricarboxylic acid cycle were accelerated. Although labelling of lactate and of citrate approached the theoretical maximum of 50%, labelling of the amino acids was always below 20%, suggesting that there is a metabolic pool or compartment that is inaccessible to exogenous substrates. Under resting conditions labelling of citrate and of glutamine from [1-13C]glucose was not detected, whereas both were labelled from [2-13C]acetate, which is considered to reflect glial metabolism. In contrast, considerable labelling of these two metabolites from [1-13C]glucose was observed in depolarized tissues, suggesting that the increased metabolism may be due to increased consumption of glucose by glial cells. The labelling patterns on depolarization from [1-13C]glucose alone and from both precursors [( 1-13C]glucose plus [2-13C]acetate) were similar, which also indicates that the changes are due to increased consumption of glucose rather than acetate.

The drought of progress in clinical brain tumor therapy provides an impetus for developing new treatments as well as methods for testing therapeutics in animal models. The inability of traditional assays to simultaneously measure tumor size, location, growth kinetics, and cell kill achieved by a treatment complicates the interpretation of therapy experiments in animal models. To address these issues, tumor volume measurements obtained from serial magnetic resonance images were used to noninvasively estimate cell kill values in individual rats with intracerebral 9L tumors after treatment with 0.5, 1, or 2 ؋ LD 10 doses of 1,3-bis(2-chloroethyl)-1-nitrosourea. The calculated cell kill values were consistently lower than those reported using traditional assays. A dose-dependent increase in 9L tumor doubling time after treatment was observed that significantly contributed to the time required for surviving cells to repopulate the tumor mass. This study reveals that increases in animal survival are not exclusively attributable to the fraction of tumor cells killed but rather are a function of the cell kill and repopulation kinetics, both of which vary with treatment dose.Brain tumors occur frequently in the human population with approximately 35,000 new cases of primary adult central nervous system tumors diagnosed in the United States each year (1). The 1,500-2,000 brain tumors reported annually in children constitute the largest group of solid pediatric neoplasms (2). Despite the use of multimodality therapy, the management of brain tumors in adults and children remains unsatisfactory. In particular, the treatment of glioblastoma multiforme constitutes a major problem caused by the lack of therapeutic responses and a median survival time of only 1 year from the initial diagnosis (3).Promising agents identified through in vitro screening assays with brain tumor cell lines subsequently are evaluated in vivo by using animal brain tumor models (4-6). These studies frequently use rodent brain tumor models (7-10), particularly the rat 9L tumor (11-29). Animal survival, colony-forming efficiency (CFE) assays of cells disaggregated from solid tumors, and measurements of excised tumor weights have been used for two decades to quantitate the efficacy of various treatments on the orthotopic 9L brain tumor (11)(12)(13)(14)(15)(16)(17)(18)(20)(21)(22)(23)(24)(25)(26)(27)(28)(29). Numerous in vitro and in vivo studies have shown that 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) is an effective treatment for the 9L brain tumor (11-15, 17, 18, 20-23, 25-29); in fact, a single bolus of BCNU achieved a 3-4 log cell kill in orthotopic tumors, resulting in a 97% increase in life span (13).BCNU is a mainstay of brain tumor chemotherapy, but the clinical outcome of patients treated solely with BCNU has not proven as efficacious as would be predicted by the responses observed in the 9L tumor model (30-33).In the present study, MRI was used for noninvasive estimation of tumor cell kill in individual animals with orthotopic 9L brain...

Hydrogen peroxide (H2O2) is a reactive oxygen species (ROS) generated in the stereoselective deamination of D-amino acids catalyzed by D-amino acid oxidase (DAAO). H2O2 readily crosses cellular membranes and damages DNA, proteins, and lipids. The scarcity of DAAO substrates in mammalian organisms and its co-localization with catalase in the peroxisomal matrix suggested that the cytotoxicity of ROS could be harnessed by administration of D-amino acids to tumor cells ectopically expressing DAAO in the cytoplasm. To evaluate this hypothesis, the cDNA encoding the highly active DAAO from the red yeast Rhodotorula gracilis was mutated to remove the carboxy-terminal peroxisomal targeting sequence. A clonal line of 9L glioma cells stably transfected with this construct (9Ldaao17) was found to synthesize active R. gracilis DAAO. Exposure of 9Ldaao17 cells to D-alanine resulted in cytotoxicity at concentrations that were nontoxic to parental 9L cells. Depletion of cellular glutathione further sensitized 9Ldaao17 cells to D-alanine (D-Ala). This result, combined with stimulation of pentose phosphate pathway activity and the production of extracellular H2O2 by 9Ldaao17 cells incubated with D-alanine implicates oxidative stress as the mediator of cytotoxicity. These results demonstrate that expression of R. gracilis DAAO in tumor cells confers chemosensitivity to D-alanine that could be exploited as a novel cancer gene therapy paradigm.

The incorporation of 13C from [1-13C]glucose and [2-13C]acetate into selected intermediary metabolites in extracts prepared from incubated cerebral-cortex slices was monitored by using 13C-n.m.r. spectroscopy under conditions of mild and severe hypoxia. Mild hypoxia had little effect on labelling of tricarboxylic-acid-cycle-related amino acids [glutamate, glutamine and gamma-aminobutyrate (GABA)], although the pool sizes of glutamate and glutamine decreased. There were large increases in the labelling of lactate and of alanine, and an increase in the pool size of lactate. In severe hypoxia, the resonances of lactate and alanine remained high, whereas those of the other intermediates decreased greatly. The pool size of GABA increased. Calculation of percentage 13C enrichments and total label incorporated showed that lactate was not further affected by severe hypoxia, but the total label in alanine and its pool size were further increased. A new resonance appeared in the phosphomonoester region of the 13C-n.m.r. spectrum only in severe hypoxia. This was unambiguously assigned to glycerol 3-phosphate from a combination of 31P- and 13C-n.m.r. spectroscopy. The percentage 13C-enrichment was calculated from the 13C-n.m.r. spectrum, and the total label incorporated was measured by g.l.c./m.s. The results are discussed in terms of the ability of lactate dehydrogenase to maintain normal levels of NADH in mild hypoxia, but not in severe hypoxia. The pyruvate which accumulates under the latter condition is channelled into alanine, and the increased NADH is reflected by the increase in glycerol 3-phosphate. We conclude that glycerol 3-phosphate and alanine may provide novel means of monitoring severe hypoxia, whereas lactate is a reliable indicator only of mild hypoxia.